Correction: Resistance profile of the HIV-1 maturation inhibitor GSK3532795 in vitro and in a clinical study
Authors:
Published in the journal:
PLoS ONE 14(11)
Category:
Correction
doi:
https://doi.org/10.1371/journal.pone.0224976
Notice of Republication
Incorrect versions of Figs 1–5 were published in error. The publisher apologizes for this error. This article was republished on October 24, 2019 to correct for this error. Please download this article again to view the correct version.
Zdroje
1. Dicker I, Zhang S, Ray N, Beno BR, Regueiro-Ren A, Joshi S, et al. (2019) Resistance profile of the HIV-1 maturation inhibitor GSK3532795 in vitro and in a clinical study. PLoS ONE 14(10): e0224076. https://doi.org/10.1371/journal.pone.0224076 31622432
Článek vyšel v časopise
PLOS One
2019 Číslo 11
- Hodné, zlé nebo ošklivé? Jak je na tom vejce?
- Top zaměstnavatelé ve zdravotnictví si hýčkají už studenty
- Přerušovaný půst může mít významná zdravotní rizika
- „Jednohubky“ z klinického výzkumu – 2025/14
- Mikroplasty a jejich riziko pro zdraví: Co všechno víme?
Nejčtenější v tomto čísle
- A daily diary study on maladaptive daydreaming, mind wandering, and sleep disturbances: Examining within-person and between-persons relations
- A 3’ UTR SNP rs885863, a cis-eQTL for the circadian gene VIPR2 and lincRNA 689, is associated with opioid addiction
- A substitution mutation in a conserved domain of mammalian acetate-dependent acetyl CoA synthetase 2 results in destabilized protein and impaired HIF-2 signaling
- Molecular validation of clinical Pantoea isolates identified by MALDI-TOF
Zvyšte si kvalifikaci online z pohodlí domova
Všechny kurzy